President Donald Trump has decided to nominate White House aide Heidi Overton to serve as commissioner of the Food and Drug Administration.

Overton currently serves as deputy director of the White House Domestic Policy Council. Multiple administration officials and people familiar with the decision confirmed the selection on Wednesday.

She would succeed Dr. Marty Makary, who resigned from the post in May following months of internal clashes and policy disputes at the agency. The FDA has experienced significant leadership turnover during the second Trump administration.

Reports indicate Overton emerged as the leading candidate after weeks of deliberations. She previously worked with the America First Policy Institute and has advised on health policy matters aligned with administration priorities.

The nomination comes amid ongoing efforts to reshape federal health agencies. Overton’s background in domestic policy is expected to influence the agency’s direction on regulatory issues, including drug approvals and vaccine policies.

Trump administration sources described the move as part of broader staffing adjustments at the FDA. No Senate confirmation timeline has been announced yet.

Overton would become the latest in a series of Trump appointees tasked with overseeing the nation’s food and drug safety regulations.